 ImmunoGen, Inc. NASDAQ:IMGN Q1 2022 Results Conference Call May 6, 2022 8:00 AM ET Company Participants Courtney OKonek - Senior Director, Corporate Communications Mark Enyedy - President, CEO Anna Berkenblit - CMO Kristen Harrington-Smith - Chief Commercial Officer Susan Altschuller - CFO Conference Call Participants Boris Peaker - Cowen Kelly Shi - Jefferies Etzer Darout - BMO Capital Markets Jessica Fye - JPMorgan John Newman - Canaccord Joe Catanzaro - Piper Sandler Michael Schmidt - Guggenheim Andy Hsieh - William Blair Jonathan Chang - SVB Securities Operator Good morning and welcome to ImmunoGens First Quarter 2022 Financial and Operating Results Conference Call. Todays conference is being recorded. 